Immune response to green fluorescent protein: Implications for gene therapy

Gene Therapy

Volumn 6, Issue 7, 1999, Pages 1305-1312

  Stripecke, R ^b   Del Carmen Villacres, M ^b   Skelton, D C ^b   Satake, N ^b   Halene, S ^b   Kohn, D B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

Cell vaccine; Dendritic cell; Gene therapy; Green fluorescent protein; Immune response; Leukemia

Indexed keywords

B7 ANTIGEN; CANCER ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; IMMUNOMODULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; CANCER IMMUNIZATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GENE THERAPY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANIMALS; ANTIGENS, CD80; GENE THERAPY; GENE TRANSFER TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; LEUKEMIA, EXPERIMENTAL; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

ANIMALIA; MURINAE;

EID: 0032812877     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300951     Document Type: Article

References (32)

1. Chalfie M et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-805.
2. Zolotukhin S et al. A 'humanized' green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646-4654.
3. Cormack BP, Valvidia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996; 173: 33-38.
4. Cheng L, Fu J, Tsukamoto A, Hawley RG. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat Biotechnol 1996; 14: 606-609.
5. Levy JP, Muldoon RR, Zolotukhin S, Link CJ. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nat Biotechnol 1996; 14: 610-614.
6. Uchida N et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA 1998; 95: 11939-11944.
7. Cheng L et al. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Therapy 1997; 4: 1013-1022.
8. Mascarenhas L et al. Gene delivery to human B-precursor acute lymphoblastic leukemia cells. Blood 1998; 92: 3537-3545.
9. Levenson VV, Transue EDE, Roninson IB. Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers. Hum Gen Ther 1998; 9: 1233-1235.
10. Aran JM, Gottesman MM, Pastan I. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and b-galactosidase or green fluorescent protein. Cancer Gene Ther 1998; 5: 195-206.
11. Chida D, Miura O, Yoshimura A, Miyajima A. Role of cytokine signaling molecules in erythroid differentiation of mouse fetal liver hematopoietic cells: functional analysis of signaling molecules by retrovirus-mediated expression. Blood 1999; 93: 1567-1578.
12. Riddel SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med 1998; 2: 216-223.
13. Bonini C et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997; 276: 1719-1724.
14. Germain RN. Antigen processing and presentation. In: Paul WE (ed). Fundamental Immunology. Raven Press: New York, 1993, pp 629-676.
15. Stripecke R et al. Immune response to Philadelphia chromosome positive acute lymphoblastic leukemia induced by expression of CD80, interleukin-2 and granulocyte-macrophage colony stimulating factor. Hum Gen Ther 1998; 9: 2049-2062.
16. Robbins PB et al. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 1998; 71: 9466-9474.
17. Mayordomo J et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med 1995; 1: 1297-1302.
18. Versahelt B et al. Retrovirally transduced CD34++ human cord blood cells generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 1998; 91: 431-440.
19. Ramiro AR et al. Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursors. Hum Gene Ther 1998; 9: 1103-1109.
20. Mazurier F et al. Rapid analysis and efficient selection of human transduced primitive hematopoietic cells using humanized S65T green fluorescent protein. Gene Therapy 1998; 5: 556-562.
21. Persons DA et al. Enforced expressions of the GATA-2 transcription factors blocks normal hematopoiesis. Blood 1999; 93: 488-499.
22. Naramura M, Hu RJ, Gu H. Mice with a fluorescent marker for interleukin 2 gene activation. Immunity 1998; 9: 209-216.
23. Hadjantonakis AK et al. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998; 76: 79-90.
24. Persons DA et al. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitate scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997; 90: 1777-1786.
25. Zhang X, Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829-3840.
26. Pear WS et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving p210 bcr/abl-transduced bone marrow. Blood 1998; 92: 3780-3792.
27. Introna M et al. Rapid retroviral infection of human haemopo-ietic cells of different lineages: efficient transfer in fresh T cells. Br J Haematol 1998; 103: 449-461.
28. Dardalhon V et al. Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum Gene Ther 1999; 10: 5-14.
29. Phillips K et al. Cell-surface markers for assessing gene transfer into human hematopoietic cells. Nature Med 1996; 10: 1154-1156.
30. Button R et al. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol 1998; 72: 5781-5788.
31. Van Hennik et al. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood 1998; 92: 4013-4022.
32. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.